 Receptors, Interleukin-1
"Receptors, Interleukin-1" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Cell surface receptors that are specific for INTERLEUKIN-1. Included under this heading are signaling receptors, non-signaling receptors and accessory proteins required for receptor signaling. Signaling from interleukin-1 receptors occurs via interaction with SIGNAL TRANSDUCING ADAPTOR PROTEINS such as MYELOID DIFFERENTIATION FACTOR 88.
| Descriptor ID |
D017472
|
| MeSH Number(s) |
D12.776.543.750.705.852.420.300
|
| Concept/Terms |
Receptors, Interleukin-1- Receptors, Interleukin-1
- Receptors, Interleukin 1
- IL1 Receptors
- Receptors, IL1
- Interleukin-1 Receptors
- Interleukin 1 Receptors
- Receptors, IL-1
- Receptors, IL 1
- IL-1 Receptors
- IL 1 Receptors
- Interleukin 1 Receptor
- Receptor, Interleukin 1
|
Below are MeSH descriptors whose meaning is more general than "Receptors, Interleukin-1".
Below are MeSH descriptors whose meaning is more specific than "Receptors, Interleukin-1".
This graph shows the total number of publications written about "Receptors, Interleukin-1" by people in this website by year, and whether "Receptors, Interleukin-1" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1993 | 8 | 7 | 15 | | 1994 | 8 | 4 | 12 | | 1995 | 5 | 2 | 7 | | 1996 | 5 | 2 | 7 | | 1997 | 5 | 6 | 11 | | 1998 | 6 | 3 | 9 | | 1999 | 5 | 4 | 9 | | 2000 | 2 | 0 | 2 | | 2001 | 1 | 4 | 5 | | 2002 | 3 | 1 | 4 | | 2003 | 1 | 2 | 3 | | 2004 | 2 | 4 | 6 | | 2005 | 2 | 5 | 7 | | 2006 | 3 | 1 | 4 | | 2007 | 0 | 4 | 4 | | 2009 | 2 | 4 | 6 | | 2010 | 2 | 2 | 4 | | 2011 | 0 | 2 | 2 | | 2012 | 3 | 0 | 3 | | 2013 | 2 | 1 | 3 | | 2014 | 5 | 3 | 8 | | 2015 | 4 | 1 | 5 | | 2016 | 2 | 4 | 6 | | 2017 | 0 | 2 | 2 | | 2018 | 3 | 3 | 6 | | 2019 | 1 | 0 | 1 | | 2020 | 0 | 2 | 2 | | 2021 | 1 | 3 | 4 | | 2022 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Receptors, Interleukin-1" by people in Profiles.
-
de Graaf DM, Teufel LU, Joosten LAB, Dinarello CA. Interleukin-38 in Health and Disease. Cytokine. 2022 04; 152:155824.
-
Griffiths M, Yang J, Vaidya D, Nies M, Brandal S, Ivy DD, Hickey F, Wolter-Warmerdam K, Austin ED, Mullen M, Pauciulo MW, Lutz KA, Rosenzweig EB, Hirsch R, Yung D, Nichols WC, Everett AD. Biomarkers of Pulmonary Hypertension Are Altered in Children with Down Syndrome and Pulmonary Hypertension. J Pediatr. 2022 02; 241:68-76.e3.
-
Javan H, Li L, Schaaf CL, Lee YS, Salama ME, Dinarello CA, Selzman CH. Interleukin-1 Receptor Antagonism Abrogates Acute Pressure Overload-Induced Murine Heart Failure. Ann Thorac Surg. 2022 07; 114(1):98-107.
-
Cavalli G, Colafrancesco S, Emmi G, Imazio M, Lopalco G, Maggio MC, Sota J, Dinarello CA. Interleukin 1a: a comprehensive review on the role of IL-1a in the pathogenesis and treatment of autoimmune and inflammatory diseases. Autoimmun Rev. 2021 Mar; 20(3):102763.
-
S?nchez-Fern?ndez A, Zandee S, Amo-Aparicio J, Charabati M, Prat A, Garlanda C, Eisenmesser EZ, Dinarello CA, L?pez-Vales R. IL-37 exerts therapeutic effects in experimental autoimmune encephalomyelitis through the receptor complex IL-1R5/IL-1R8. Theranostics. 2021; 11(1):1-13.
-
de Graaf DM, Jaeger M, van den Munckhof ICL, Ter Horst R, Schraa K, Zwaag J, Kox M, Fujita M, Yamauchi T, Mercurio L, Madonna S, Rutten JHW, de Graaf J, Riksen NP, van de Veerdonk FL, Netea MG, Joosten LAB, Dinarello CA. Reduced concentrations of the B cell cytokine interleukin 38 are associated with cardiovascular disease risk in overweight subjects. Eur J Immunol. 2021 03; 51(3):662-671.
-
Jaramillo AM, Evans CM. It Takes 1 for Type 2: IL-1 Receptor Mediates Eosinophilia in Scnn1b Transgenic Mice. Am J Respir Cell Mol Biol. 2020 03; 62(3):269-270.
-
Dinarello CA. The IL-1 family of cytokines and receptors in rheumatic diseases. Nat Rev Rheumatol. 2019 10; 15(10):612-632.
-
Mercurio L, Morelli M, Scarponi C, Eisenmesser EZ, Doti N, Pagnanelli G, Gubinelli E, Mazzanti C, Cavani A, Ruvo M, Dinarello CA, Albanesi C, Madonna S. IL-38 has an anti-inflammatory action in psoriasis and its expression correlates with disease severity and therapeutic response to anti-IL-17A treatment. Cell Death Dis. 2018 10 30; 9(11):1104.
-
Dinarello CA. An Interleukin-1 Signature in Breast Cancer Treated with Interleukin-1 Receptor Blockade: Implications for Treating Cytokine Release Syndrome of Checkpoint Inhibitors. Cancer Res. 2018 09 15; 78(18):5200-5202.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|